Fate Therap

Forecast & Rating11 analysts currently cover Fate Therap, with about 45.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $5.74, about 147.6% upside from the current price of $2.32. Price targets range from $2.20 to $8.00 — a wide spread, showing clear disagreement over just how much Fate Therap can rise. Historically, about 28.8% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Fate Therap are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 25, 2026; for reference only and not investment advice.